Be part of the only conference that presents strategies and solutions for every link of the controlled substances supply chain.

Connect with government officials and key industry stakeholders from throughout the controlled substances supply chain to examine the latest legal and regulatory developments impacting the industry. Attend and learn how to best conform business practices to meet industry and regulatory demands, bolster compliance programs, mitigate risk, and reduce liability.

HEAR FROM OUR 2023 CO-CHAIRS
Conference Co-Chairs
Speaker

Gustav Eyler

Partner
Gibson, Dunn, & Crutcher LLP
Former Director of Consumer Protection Branch, U.S. Department of Justice

Speaker

Jolie Apicella

Partner
Wiggin & Dana LLP
Former AUSA, Chief of Healthcare Fraud, Eastern District of New York

Speaker

Cori Rizman

Director, Compliance – Controlled Substances Oversight Region North America
Fresenius-Kabi USA
Former Diversion Group Supervisor, DEA

Government Keynotes
Speaker

Dominic Chiapperino, Ph.D.

Director, Controlled Substance Staff
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Speaker

Amanda Liskamm

Director, Consumer Protection Branchh
U.S. Department of Justice

Government Speakers
Speaker

Matthew Feeley

Deputy Chief & Healthcare Fraud Coordinator, USAO SDFL Civil Division
U.S. Department of Justice

Speaker

Monica Hanna

Special Counsel
Office of the NY State Attorney General

Speaker

Justin G. Wood

Diversion Program Manager, Washington Division
Drug Enforcement Administration

Speaker

Gabriel H. Scannapieco

Assistant Director, Consumer Protection Branch
United States Department of Justice

Speaker

Jonathan Lenzner

Chief of Staff
Federal Bureau of Investigations

Speaker

Natalie Waites

Assistant Director, Fraud Section, Civil Division
U.S. Department of Justice

Speaker

Francis Godwin

Director, Office of Manufacturing Quality
U.S. Food and Drug Administration

Speaker

Scott B. Dahlquist

Opioid Coordinator, Consumer Protection Branch
U.S. Department of Justice

Speaker

Arun Rao

Deputy Assistant Attorney General
U.S. Department of Justice, Civil Division

Speaker

Anthony J. Nardozz

Assistant Director
U.S. Department of Justice, Consumer Protection Branch, Civil Division

Speaker

Lisa Miller

Deputy Assistant Attorney General, Fraud and Appellate Sections
U.S. Department of Justice, Criminal Division

Industry Thought Leaders Will Help You
  • ASSESS the current status of the National Opioid Litigation and MDL Settlements
  • ANALYZE the therapeutic potential of marijuana and psychedelics
  • EVALUATE the role of Telemedicine in controlled substances prescribing, distribution, and abuse
  • DEVELOP a comprehensive Controlled Substances Compliance Program
  • RESPOND effectively to DEA and FDA investigations
Here’s what some of our attendees had to say
Quote Icon

This conference was spot on with the issues we are facing everyday.

Amy D’Anna
Novartis Institutes for Biomedical Research
Quote Icon

It was great to hear from current and former industry leaders and experts from DEA, US AG offices, FDA, etc. Hearing about the current events and upcoming trends/expectations was valuable.

Jaime McDermott
Kroger Health
Quote Icon

As the Director of Compliance for IPC, I was extremely pleased with last year’s speakers and the insight they provided into the latest controlled substance regulations.

Brian Rucker
Independent Pharmacy Cooperative
Safety Plan

View our return to in-person All Secure safety plan.

Worry Free
Concerned About Traveling?
Check out our WORRY-FREE GUARANTEE

Register at the preferred early rate with our worry free cancellation guarantee.

Learn More
screenshot
icon
Livestream Also Available

Join a real-time interactive broadcast of the in-person conference virtually from your location.

Learn More
Related Conferences
Event Thumbnail Image
Event Thumbnail Image
Event Thumbnail Image